Study of the Vascular Effects of Serelaxin

Summary

This was a mechanistic study in patients with coronary artery disease on the effects of Serelaxin on micro- and macrovascular function.

Timeline

Start

2014-02-03

Primary completion

2016-08-17

Completion

2016-08-17

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Serelaxin vs Placebo; p = 0.438; Standard Error -0.1116 (95% CI -0.399 to 0.176); ANCOVA NCT01979614 ↗

Drugs

Indications